PIM1 and breast neoplasm: Interestingly, this subset with higher PIM1/2 expression has poor prognosis (Figure 4D–4G) that is also observed in relapse (Figure 4H) and resistance to therapy (Figure 4I, 4J), at least in breast tumors.